Feb 2, 2021   SOURCE: PR NewsWire

Clinical Trial Imaging Market Size Worth $1.4 Billion By 2028 | CAGR: 6.1%: Grand View Research, Inc.

SAN FRANCISCO, Feb. 2, 2021 /PRNewswire/ -- The global clinical trial imaging market size is expected to reach USD 1.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.1% from 2021 to 2028. The increasing R&D spending to develop new drugs and therapies to treat chronic diseases is propelling the market growth.

https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

Clinical trial imaging makes use of imaging technology in clinical trials for seeing the interior parts of the body. The images obtained from clinical trial imaging are used to examine drug activity. Clinical trial imaging provides rapid, detail, and precise screening. The use of clinical trial imaging has rapidly increased in all phases of the clinical trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

Key suggestions from the report:

    --  Based on service, project and data management services held the largest
        share in 2020 due to the growing requirement of data management and
        workflow for clinical trial imaging
    --  Operational imaging services held a significant share in 2020. They
        include imaging modalities such as MRI, CT scan, X-ray, ultrasound, OCT,
        PET, and SPECT. CT scan modality is gaining popularity due to its
        non-invasive nature and its ability to provide detailed information
        about the disease for enhanced treatment
    --  The others application segment held the largest share in 2020. This
        segment includes oncology, neurology, and musculoskeletal. Market
        players such as ICON, Bioclinica, Navitas Life Sciences, and Paraxel
        International are developing their clinical trial imaging services for
        these applications
    --  By end-use, CROs held the largest share in 2020 due to increasing
        investments in the field of research and development and snowballing
        outsourcing activities by the pharmaceutical and biotechnology companies
        to cut down the cost and time and patent expiration
    --  North America dominated the market in 2020 due to the increasing
        geriatric population, rising chronic diseases, and growing demand for
        treatment options.

Read 111 page research report with ToC on "Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Service (Project and Data Management, System and Technology Support Services), By Application, By End Use, By Region, And Segment Forecasts, 2021 - 2028" at: https://www.grandviewresearch.com/industry-analysis/clinical-trial-imaging-market

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities, such as EMA and FDA, to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuroimaging. Imaging biomarkers are effective in radiological reads. This provides a radiological reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility.

Grand View Research has segmented the global clinical trial imaging market based on service, application, end-use, and region:

    --  Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2016 -
        2028)
        --  Clinical Trial Design and Consultation Services
        --  Reading and Analytical Services
        --  Operational Imaging Services
            --  Computed Tomography (CT) Scan
            --  MRI (Magnetic Resonance Imaging)
            --  X-Ray
            --  Ultrasound
            --  Optical Coherence Tomography (OCT)
            --  Others
        --  System and Technology Support Services
        --  Project and Data Management
    --  Clinical Trial Imaging Application Outlook (Revenue, USD Million, 2016 -
        2028)
        --  NASH
        --  CKD
        --  Diabetes
        --  Cardiovascular Diseases
        --  Others
    --  Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2016 -
        2028)
        --  Biotechnology and Pharmaceutical companies
        --  Medical Devices Manufacturers
        --  Academic and Government Research Institutes
        --  Contract Research Organizations (CROs)
        --  Others
    --  Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2016 -
        2028)
        --  North America
            --  U.S.
            --  Canada
        --  Europe
            --  U.K.
            --  Germany
            --  France
            --  Italy
            --  Spain
        --  Asia Pacific
            --  India
            --  China
            --  Japan
            --  Thailand
            --  South Korea
        --  Latin America
            --  Brazil
            --  Mexico
            --  Argentina
            --  Colombia
        --  Middle East & Africa
            --  South Africa
            --  Saudi Arabia
            --  UAE

List of Key Players of Clinical Trial Imaging Market

    --  Parexel International Corporation
    --  Intrinsic Imaging
    --  Bioclinica Inc.
    --  Icon PLC
    --  Radiant Sage
    --  Navitas Life Sciences
    --  Resonance Health
    --  IXICO PLC
    --  Medpace.

Find more research reports on Medical Devices Industry, by Grand View Research:

    --  Medical Imaging Market - The global medical imaging market size was
        valued at USD 15.9 billion in 2020 and is expected to expand at a
        compound annual growth rate (CAGR) of 5.2% from 2021 to 2028.
    --  Medical Imaging Outsourcing Market - The global medical imaging
        outsourcing market size was valued at USD 6.48 billion in 2019 and is
        expected to grow at a compound annual growth rate (CAGR) of 4.8% from
        2020 to 2027.
    --  Healthcare Contract Research Organization Market - The global healthcare
        contract research organization market size was valued at USD 37.1
        billion in 2019 and is expected to register a CAGR of 6.6% over the
        forecast period.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter

View original content:http://www.prnewswire.com/news-releases/clinical-trial-imaging-market-size-worth-1-4-billion-by-2028--cagr-6-1-grand-view-research-inc-301219718.html

SOURCE Grand View Research, Inc.